CAMBRIDGE, Mass., Oct. 4, 2023 /PRNewswire/ — Flare Therapeutics Inc., a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, today announced a poster presentation highlighting an artificial intelligence-based model…